J A Idoko

Summary

Publications

  1. ncbi request reprint Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria
    N D Sirisena
    Department of Medicine, Jos University Teaching Hospital, P M B 2076, Jos, Plateau State, Nigeria
    Niger Postgrad Med J 9:7-10. 2002
  2. doi request reprint "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria
    John Idoko
    National Agency for the Control of AIDS, Abuja, Nigeria
    BMC Public Health 15:349. 2015
  3. doi request reprint A clinician's experience with the President's Emergency Plan for AIDS Relief in Nigeria: a transformative decade of hope
    John Idoko
    National Agency for the Control of AIDS, Abuja, Nigeria
    Health Aff (Millwood) 31:1422-8. 2012
  4. pmc Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria
    Agatha Ani
    Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 10:189. 2010
  5. ncbi request reprint Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective
    J A Idoko
    AIDS Prevention Imitative in Nigeria APIN Centre, Jos University Teaching Hospital JUTH, Jos, Nigeria
    Int J STD AIDS 18:760-3. 2007
  6. doi request reprint Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria
    P A Agaba
    AIDS Prevention Initiative Nigeria APIN Centre, Jos University Teaching Hospital, Jos, Plateau State, Nigeria
    Int J STD AIDS 20:410-3. 2009
  7. ncbi request reprint Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians
    O O Agbaji
    Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria
    West Afr J Med 30:164-8. 2011
  8. ncbi request reprint The clinical features of HIV/AIDS at presentation at the Jos University Teaching Hospital
    C Akolo
    AIDS Prevention Initiative Nigeria Centre, Jos University Teaching Hospital, Jos, Nigeria
    Niger J Med 17:83-7. 2008
  9. ncbi request reprint Partner disclosure of HIV status among HIV positive mothers in Northern Nigeria
    A S Sagay
    Jos University Teaching Hospital, Nigeria
    Afr J Med Med Sci 35:119-23. 2006
  10. doi request reprint Patients who present late to HIV care and associated risk factors in Nigeria
    P A Agaba
    Department of Family Medicine, University of Jos, Jos, Nigeria AIDS Prevention Initiative Nigeria Plus, Jos University Teaching Hospital, Jos, Nigeria
    HIV Med 15:396-405. 2014

Collaborators

  • E I Agaba
  • P J Kanki
  • Z Hassan
  • E A Anteyi
  • O Otitoloju
  • Soloman A Sagay
  • O O Agbaji
  • P A Agaba
  • A S Sagay
  • H M Sule
  • J Musa
  • Agatha Ani
  • S S Gomerep
  • G E Imade
  • M O Njoku
  • N D Sirisena
  • C Akolo
  • T Jolayemi
  • P Ugoagwu
  • I O Abah
  • K D Falang
  • D Jelpe
  • P Okonkwo
  • A O Ebonyi
  • P N Ekeh
  • G C Job
  • N Nyango
  • S T Meloni
  • P O Ugoagwu
  • E Ekong
  • R Murphy
  • B Taiwo
  • Torbjørn Bruvik
  • D Obaseki
  • B P Badung
  • Yetunde Okoh
  • Patricia Agaba
  • Ulf R Dahle
  • M O Akanbi
  • S O Ugoya
  • P Agaba
  • O A Agbaji
  • Oche Agbaji
  • N G Ladep
  • L Apena
  • R O Ojoh
  • B Badung
  • M A Mu'azu
  • G N Ladep
  • C O Ukoli
  • C C Ekwempu
  • N Malu
  • A Babalola
  • G Daniyan
  • E Isamade
  • S Otowo
  • C Barau
  • A Zamani

Detail Information

Publications15

  1. ncbi request reprint Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria
    N D Sirisena
    Department of Medicine, Jos University Teaching Hospital, P M B 2076, Jos, Plateau State, Nigeria
    Niger Postgrad Med J 9:7-10. 2002
    ..This calls for health education of the general population on preventive measures to check the spread of the virus in the community...
  2. doi request reprint "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria
    John Idoko
    National Agency for the Control of AIDS, Abuja, Nigeria
    BMC Public Health 15:349. 2015
    ..The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria...
  3. doi request reprint A clinician's experience with the President's Emergency Plan for AIDS Relief in Nigeria: a transformative decade of hope
    John Idoko
    National Agency for the Control of AIDS, Abuja, Nigeria
    Health Aff (Millwood) 31:1422-8. 2012
    ....
  4. pmc Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria
    Agatha Ani
    Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 10:189. 2010
    ..Nigeria has a high tuberculosis incidence, and genotyping studies of Mycobacterium tuberculosis Complex (MTC) in the country are necessary in order to improve our understanding of the epidemic...
  5. ncbi request reprint Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective
    J A Idoko
    AIDS Prevention Imitative in Nigeria APIN Centre, Jos University Teaching Hospital JUTH, Jos, Nigeria
    Int J STD AIDS 18:760-3. 2007
    ..We, therefore, strongly support the use of treatment support in our settings...
  6. doi request reprint Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria
    P A Agaba
    AIDS Prevention Initiative Nigeria APIN Centre, Jos University Teaching Hospital, Jos, Plateau State, Nigeria
    Int J STD AIDS 20:410-3. 2009
    ..We recommend specific AIDS-KS therapy in addition to highly active antiretroviral therapy in order to improve survival...
  7. ncbi request reprint Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians
    O O Agbaji
    Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria
    West Afr J Med 30:164-8. 2011
    ..Reports of renal dysfunction in Tenofovir Disoproxil Fumarate (TDF)-treated HIV-1 infected patients have raised concerns about potential nephrotoxicity...
  8. ncbi request reprint The clinical features of HIV/AIDS at presentation at the Jos University Teaching Hospital
    C Akolo
    AIDS Prevention Initiative Nigeria Centre, Jos University Teaching Hospital, Jos, Nigeria
    Niger J Med 17:83-7. 2008
    ..This study was therefore conducted to determine the commonest symptoms and signs at presentation in HIV-infected individuals at the Jos University Teaching Hospital...
  9. ncbi request reprint Partner disclosure of HIV status among HIV positive mothers in Northern Nigeria
    A S Sagay
    Jos University Teaching Hospital, Nigeria
    Afr J Med Med Sci 35:119-23. 2006
    ..0% was violent. The reactions of partners of HIV positive mothers to disclosure of their wives' HIV status are predominantly supportive. This should strengthen strategies to promote partner disclosure...
  10. doi request reprint Patients who present late to HIV care and associated risk factors in Nigeria
    P A Agaba
    Department of Family Medicine, University of Jos, Jos, Nigeria AIDS Prevention Initiative Nigeria Plus, Jos University Teaching Hospital, Jos, Nigeria
    HIV Med 15:396-405. 2014
    ..Our objectives were to assess trends in late presentation and advanced HIV disease (AHD) and determine associated risk factors...
  11. ncbi request reprint Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria
    S S Gomerep
    APIN PLUS PEPFAR HARVARD, Jos University Teaching Hospital, Jos, Nigeria
    Niger J Med 19:395-9. 2010
    ..It is an important cause of morbidity and mortality There is paucity of data on the prevalence of CM in Nigeria. We aimed to determine the frequency of CM, the clinical presentation and immunological profile...
  12. ncbi request reprint Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria
    O O Agbaji
    Pharmacy Department, Jos University Teaching Hospital, Jos, Nigeria
    Curr HIV Res 13:184-92. 2015
    ..We evaluated the incidence of and risk factors for treatment discontinuation (TD) in a large adult HIV population on ART in Nigeria...
  13. ncbi request reprint Renal disease in the acquired immunodeficiency syndrome in north central Nigeria
    E I Agaba
    Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria
    Niger J Med 12:120-5. 2003
    ..The brunt of the human immunodeficiency virus infection/the acquired immunodeficiency syndrome is largely borne by communities in sub-Saharan Africa. We describe renal disease in Nigerians with the acquired immunodeficiency syndrome...
  14. ncbi request reprint CD4+ T-lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV-1) and healthy population in Jos, Nigeria
    M O Njoku
    AIDS and Leishmaniasis Research Laboratory, Department of Zoology, University of Jos, P M B 2084, Jos, Plateau State
    Niger Postgrad Med J 10:135-9. 2003
    ..This study therefore establishes a local standard range for CD4+LC in healthy and HIV infected Nigerians which can serve as reliable indices for HIV induced immune impairment and for monitoring effectiveness of HIV therapy...
  15. ncbi request reprint A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients
    J A Idoko
    Jos University Teaching Hospital, Nigeria
    West Afr J Med 21:83-6. 2002
    ....